Cargando…

CD73 Promotes Chronic Lymphocytic Leukemia

SIMPLE SUMMARY: Many patients with chronic lymphocytic leukemia (CLL) still fail current therapies. CD73 is a novel therapeutic target for solid tumors, but its role in CLL remains unclear. The aim of our study was to investigate the therapeutic potential of targeting CD73 in CLL. Using genetically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allard, David, Chrobak, Pavel, Bareche, Yacine, Allard, Bertrand, Tessier, Priscilla, Bergeron, Marjorie A., Johnson, Nathalie A., Stagg, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264813/ https://www.ncbi.nlm.nih.gov/pubmed/35804900 http://dx.doi.org/10.3390/cancers14133130

Ejemplares similares

The CD73 immune checkpoint promotes tumor cell metabolic fitness
por: Allard, David, et al.
Publicado: (2023)

CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination
por: Allard, David, et al.
Publicado: (2018)

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
por: Allard, Bertrand, et al.
Publicado: (2012)

Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
por: Allard, Bertrand, et al.
Publicado: (2023)

On the mechanism of anti-CD39 immune checkpoint therapy
por: Allard, David, et al.
Publicado: (2020)

High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
por: Bareche, Yacine, et al.
Publicado: (2021)

The A2A adenosine receptor regulates the formation of new lymphatic vessels in inflammatory microenvironments
por: Allard, Bertrand, et al.
Publicado: (2015)

The double-edge sword effect of anti-CD73 cancer therapy
por: Stagg, John
Publicado: (2012)

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73
Publicado: (1995)

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014)

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
por: Ahmadi, Parimah, et al.
Publicado: (2020)

A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
por: Mediavilla-Varela, Melanie, et al.
Publicado: (2017)

CD73 promotes colitis-associated tumorigenesis in mice
por: Liu, Xuan-Hui, et al.
Publicado: (2020)

Number of Circulating CD73‐Expressing Lymphocytes Correlates With Survival After Cardiac Arrest
por: Ryzhov, Sergey, et al.
Publicado: (2019)

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis
por: Messaoudi, Nouredin, et al.
Publicado: (2020)

The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014)

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia
por: Gutjahr, Julia Christine, et al.
Publicado: (2015)

Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases
por: Saber, Ralph, et al.
Publicado: (2023)

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia
por: Villuendas Vázquez, Òscar, et al.
Publicado: (2020)

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020)

TAp73 promotes anabolism
por: Amelio, Ivano, et al.
Publicado: (2014)

Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over
por: Kling, Lovis, et al.
Publicado: (2017)

CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance
por: D’Arena, Giovanni, et al.
Publicado: (2020)

YIM-P44. Reduced expression of cd73 on jia synovial lymphocytes is related to cell proliferation
por: Gordon-Smith, Sophie Botta, et al.
Publicado: (2014)

The Clinical Significance of CD73 in Cancer
por: Bach, Niklas, et al.
Publicado: (2023)

CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2021)

CD73(+) Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
por: Li, Qiong, et al.
Publicado: (2021)

Simultaneous finding of chronic lymphocytic leukemia and residual hairy cell leukemia using a lymphocyte‐binding anti‐CD antibody microarray
por: Khvastunova, Alina N., et al.
Publicado: (2018)

A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
por: Horenstein, Alberto L, et al.
Publicado: (2013)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

Prospective isolation of human fibroadipogenic progenitors with CD73
por: Goloviznina, Natalya A., et al.
Publicado: (2020)

Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia
Publicado: (1989)

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
por: Marconato, Maddalena, et al.
Publicado: (2022)

CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
por: Petruk, Nataliia, et al.
Publicado: (2023)

Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia
por: Abdelgader, Enaam Abdelrhman, et al.
Publicado: (2018)

Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia
por: Demir, Cengiz, et al.
Publicado: (2017)

Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia
por: Aref, Salah, et al.
Publicado: (2023)

Deletion of CD73 increases exercise power in mice
por: Aguiar, Aderbal S., et al.
Publicado: (2021)

Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia
por: Jovanovic, Danijela, et al.
Publicado: (2014)

CD73 Is Critical for the Resolution of Murine Colonic Inflammation
por: Bynoe, Margaret S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pq4okr8kbpbc95bmquf6kgjsqe